An earlier randomized controlled trial of prevention care management (PCM) found significant improvement in breast, cervical, and colorectal cancer-screening rates among women attending Community Health Centers but required substantial research support. This study evaluated the impact of a streamlined PCM delivered through a Medicaid managed care organization (MMCO), an infrastructure with the potential to sustain this program for the long term.
Methods
This randomized trial was conducted within an MMCO serving New York City between May 2005 and December 2005. A total of 1,316 women aged 40 to 69 years and not up to date for at least 1 targeted cancer-screening test were randomized to either PCM or a comparison group. Women in the PCM group received up to 3 scripted telephone calls to identify barriers and provide support to obtain any needed breast, cervical, and colorectal cancer-screening tests. Women in the comparison group received a modified version of the MMCO's established mammography telephone outreach program, also in up to 3 calls. Women in both groups received a financial incentive on confirmation that they had received a mammogram. Screening status was assessed through MMCO administrative data. Groups were compared using odds ratios.
Results
In an intent-to-treat comparison adjusted for baseline screening status, PCM women were 1.69 times more likely to be up-to-date for colorectal cancer-screening tests at follow-up than women in the comparison group (95% confidence interval, 1.03-2.77). Follow-up screening rates for cervical and breast cancer did not differ significantly between study groups on an intent-to-treat basis.
Conclusions
The abbreviated PCM telephone intervention was feasible to deliver through an MMCO and improved screening for 1 cancer. This approach has the potential to improve cancer-screening rates significantly in settings that can provide telephone support to women known to be overdue.
cancer screening intervention, Medicaid managed care, prevention care management, breast cervical colorectal screening, community health center, randomized trial screening, health disparities cancer, mammography screening promotion, cervical cancer screening, evidence-based screening program
PMID 17664498 17664498 DOI 10.1370/afm.701 10.1370/afm.701
Cite this article
Dietrich, A. J., Tobin, J. N., Cassells, A., Robinson, C. M., Reh, M., Romero, K. A., Flood, A. B., & Beach, M. L. (2007). Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization. *Annals of family medicine*, *5*(4), 320-327. https://doi.org/10.1370/afm.701
Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Reh M, Romero KA, et al. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization. Ann Fam Med. 2007;5(4):320-327. doi:10.1370/afm.701
Dietrich, A. J., et al. "Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization." *Annals of family medicine*, vol. 5, no. 4, 2007, pp. 320-327.
GBD 2021 AEMT Collaborators, 2026The Korean journal of internal medicine
BACKGROUND/AIMS: This study aims to evaluate the global burden of adverse effects of medical treatment (AEMT) using data from the Global Burden of Disease Study (GBD) 2021.
METHODS: Data were extract...
GBD 2023 Disease and Injury and Risk Factor Collaborators, 2025Lancet (London, England)
BACKGROUND: For more than three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has provided a framework to quantify health loss due to diseases, injuries, and associate...
GBD 2023 Causes of Death Collaborators, 2025Lancet (London, England)
BACKGROUND: Timely and comprehensive analyses of causes of death stratified by age, sex, and location are essential for shaping effective health policies aimed at reducing global mortality. The Global...
Modern urban human activities are largely restricted to the indoors, deprived of direct sunlight containing visible and near-infrared (NIR) wavelengths at high irradiance levels. Therapeutic exposure ...